SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-006834
Filing Date
2015-08-10
Accepted
2015-08-10 16:14:00
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cala-10q_20150630.htm 10-Q 1349307
2 EX-31.1 cala-ex311_2015063010.htm EX-31.1 11635
3 EX-31.2 cala-ex312_201506307.htm EX-31.2 11596
4 EX-32.1 cala-ex321_201506306.htm EX-32.1 6063
5 EX-32.2 cala-ex322_201506309.htm EX-32.2 6270
  Complete submission text file 0001564590-15-006834.txt   4271841

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cala-20150630.xml EX-101.INS 923076
7 XBRL TAXONOMY EXTENSION SCHEMA cala-20150630.xsd EX-101.SCH 27188
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cala-20150630_cal.xml EX-101.CAL 29587
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cala-20150630_def.xml EX-101.DEF 64998
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20150630_lab.xml EX-101.LAB 203683
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20150630_pre.xml EX-101.PRE 156958
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36644 | Film No.: 151040924
SIC: 2834 Pharmaceutical Preparations